Indications and uses
cures most athlete's foot between the toes. Effectiveness on the bottom or sides of foot is unknown. cures most jock itch and ringworm relieves itching, burning, cracking, and scaling which accompany these conditions
cures most athlete's foot between the toes. Effectiveness on the bottom or sides of foot is unknown. cures most jock itch and ringworm relieves itching, burning, cracking, and scaling which accompany these conditions
adults and children 12 years and older: use the tip of the cap to break the seal and open the tube wash the affected skin with soap and water and dry completely before applying for athlete's foot between the toes : apply to affected skin between and around the toes twice a day for 1 week (morning and night), or once a day for 4 weeks, or as directed by a doctor. Wear well-fitting, ventilated shoes. Change shoes an...
do not use if seal on tube is broken or not visible store between 20° to 25°C (68° to 77°F)
Drug Facts
Butenafine hydrochloride 1%
Antifungal
For external use only
When using this product do not get into the eyes. If eye contact occurs, rinse thoroughly with water.
Stop use and ask a doctor if too much irritation occurs or irritation gets worse
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
benzyl alcohol, cetyl alcohol, diethanolamine, glycerin, glyceryl monostearate SE, polyoxyethylene (23) cetyl ether, propylene glycol dicaprylate, purified water, sodium benzoate, stearic acid, white petrolatum
866-360-3226
Distributed by MSD Consumer Care, Inc., PO Box 377, Memphis, TN 38151 USA, a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ USA.
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 11523-7154-3 | GM - Gram | 11523-7154 | bc0b2d8d-4da3-43d7-a781-84d6b366d3ab | 1 | 2013-09-04 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Butenafine Hydrochloride | ACTIVE INGREDIENT | R8XA2029ZI | 2 | |
| Butenafine | ACTIVE MOIETY | 91Y494NL0X | 2 | |
| benzyl alcohol | INACTIVE INGREDIENT | LKG8494WBH | 2 | |
| ceteth-23 | INACTIVE INGREDIENT | 495CTZ441V | 2 | |
| cetyl alcohol | INACTIVE INGREDIENT | 936JST6JCN | 2 | |
| diethanolamine | INACTIVE INGREDIENT | AZE05TDV2V | 2 | |
| glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 2 | |
| petrolatum | INACTIVE INGREDIENT | 4T6H12BN9U | 2 | |
| propylene glycol dicaprylate | INACTIVE INGREDIENT | 581437HWX2 | 2 | |
| sodium benzoate | INACTIVE INGREDIENT | OJ245FE5EU | 2 | |
| stearic acid | INACTIVE INGREDIENT | 4ELV7Z65AP | 2 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 11523-7154 | 11523-7154-1, 11523-7154-2, 11523-7154-3, 11523-7154-4 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| BENZYL ALCOHOL | LKG8494WBH | IACT |
| CETYL ALCOHOL | 936JST6JCN | IACT |
| DIETHANOLAMINE | AZE05TDV2V | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| CETETH-23 | 495CTZ441V | IACT |
| PROPYLENE GLYCOL DICAPRYLATE | 581437HWX2 | IACT |
| WATER | 059QF0KO0R | IACT |
| SODIUM BENZOATE | OJ245FE5EU | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
| PETROLATUM | 4T6H12BN9U | IACT |
| BUTENAFINE HYDROCHLORIDE | R8XA2029ZI | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| glycerin | GLYCERIN | PDC6A3C0OX | PASTE, DENTIFRICE / DENTAL | 18 %w/w | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | LOTION / TOPICAL | 25 %w/w | ||
| sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | POWDER, FOR SOLUTION / ORAL | 98 mg | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | INJECTION, SUSPENSION / SOFT TISSUE | 40 mg | ||
| cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | SUSPENSION / AURICULAR (OTIC) | 1 %w/v | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | SOAP / TOPICAL | 0.85 %w/w | ||
| cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | TABLET, ORALLY DISINTEGRATING / ORAL | 9 mg | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | INJECTION, SUSPENSION / INTRASYNOVIAL | 18 mg | ||
| sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | PASTE, DENTIFRICE / DENTAL | 0.5 %w/w | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | TABLET / ORAL | 1.06 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | LOTION / TOPICAL | 4000 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / RESPIRATORY (INHALATION) | 5 %w/w | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | SOLUTION / INTRAVENOUS | 242 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | CREAM / VAGINAL | 1088 mg | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVERNOUS | 18 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | CREAM / TOPICAL | 190 mg | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | GEL / VAGINAL | 100 mg | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 144 mg | ||
| diethanolamine | DIETHANOLAMINE | AZE05TDV2V | CREAM / TOPICAL | 0.3 %w/w | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | SPRAY / NASAL | 5 mg | ||
| cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | AEROSOL, FOAM / TOPICAL | 82 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | SOLUTION / TOPICAL | 2 %w/w | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | TABLET, ORALLY DISINTEGRATING / ORAL | 10 mg | ||
| cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | AEROSOL, FOAM / RECTAL | 17 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| glycerin | GLYCERIN | PDC6A3C0OX | PASTE / ORAL | 3822 mg | ||
| cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | CAPSULE, DELAYED RELEASE / ORAL | 59 mg | ||
| cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | CREAM / TOPICAL | 1280 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, EMULSION / INTRAVENOUS | 24100 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / AURICULAR (OTIC) | NA | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | CAPSULE, EXTENDED RELEASE / ORAL | 1.23 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / ORAL | 32400 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | IMPLANT / SUBCUTANEOUS | 1.04 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | CAPSULE / VAGINAL | NA | ||
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| glycerin | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | AEROSOL, FOAM / TOPICAL | 7.9 %w/w | ||
| sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | INJECTION / INTRAVENOUS | 864 mg | ||
| sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | GRANULE / ORAL | NA | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / VAGINAL | 227.9 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOAP / TOPICAL | 0.76 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | OINTMENT / TOPICAL | 15 %w/w | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / VAGINAL | 4084 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | TABLET / ORAL | 42 mg | ||
| sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | FILM / BUCCAL | 1 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | TABLET, CHEWABLE / ORAL | 12 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | EMULSION / OPHTHALMIC | 3 mg | ||
| sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | SYSTEM / TOPICAL | 2 mg | ||
| sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | INJECTION, EMULSION / INTRAVENOUS | 0.1 %w/v | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | CREAM / TOPICAL | 160 mg | ||
| cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | CREAM / VAGINAL | 200 mg | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | INJECTION / SUBCUTANEOUS | 90 mg | ||
| sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | SPONGE / TOPICAL | NA |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021307-001 | LOTRIMIN ULTRA | BUTENAFINE HYDROCHLORIDE | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N021307-001 | LOTRIMIN ULTRA | 1% | CREAM / TOPICAL | RLD, RS | 2001-12-07 | 3a93d1ddd44b… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 198668a2-3429-2d88-e063-6294a90a75ad | 0eadac26-4619-4227-9dda-28e739d77a87 | 2024-05-28 | Warnings | 0eadac26-4619-4227-9dda-28e739d77a87 |
Adverse event summaries are temporarily unavailable. Other product information remains available.